Cytokine profile in degenerated painful intervertebral disc: variability with respect to duration of symptoms and type of disease

Spine Journal

Volumn 16, Issue 7, 2016, Pages 857-861

  Altun, Idiris ^a  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

Cytokines; Duration of symptoms; IL 10; IL 1 ; IL 6; Intervertebral disc, degeneration; Low back pain; Nucleus pulposus; TNF

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; CYTOKINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISCECTOMY; DISEASE DURATION; FEMALE; HUMAN; HUMAN TISSUE; INTERVERTEBRAL DISK DEGENERATION; LEG PAIN; LOW BACK PAIN; MALE; NUCLEUS PULPOSUS; PRIORITY JOURNAL; TISSUE LEVEL; INTERVERTEBRAL DISC DEGENERATION; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; CYTOKINES; DISKECTOMY; FEMALE; HUMANS; INTERVERTEBRAL DISC DEGENERATION; MALE; MIDDLE AGED; NUCLEUS PULPOSUS;

EID: 84991508577     PISSN: 15299430     EISSN: 18781632     Source Type: Journal    
DOI: 10.1016/j.spinee.2016.03.019     Document Type: Article

References (22)

1. [1] Richardson, S.M., Doyle, P., Minogue, B.M., Gnanalingham, K., Hoyland, J.A., Increased expression of matrix metalloproteinase-10, nerve growth factor and substance P in the painful degenerate intervertebral disc. Arthritis Res Ther, 11, 2009, R126.
2. [2] Andrade, P., Hoogland, G., Garcia, M.A., Steinbusch, H.W., Daemen, M.A., Visser-Vandewalle, V., Elevated IL-1β and IL-6 levels in lumbar herniated discs in patients with sciatic pain. Eur Spine J 22 (2013), 714–720.
3. [3] Koes, B.W., van Tulder, M.W., Peul, W.C., Diagnosis and treatment of sciatica. BMJ 334 (2007), 1313–1317.
4. [4] Legrand, E., Hoppé, E., Bouvard, B., Masson, C., Audran, M., Disc herniation-induced sciatica: medical or surgical treatment?. Rev Prat 58 (2008), 285–293.
5. [5] Schroeder, M., Viezens, L., Schaefer, C., Friedrichs, B., Algenstaedt, P., Ruther, W., et al. Chemokine profile of disc degeneration with acute or chronic pain. J Neurosurg Spine 18 (2013), 496–503.
6. [6] Moore, R.J., The vertebral end-plate: what do we know?. Eur Spine J 9 (2000), 92–96.
7. [7] Wittenberg, R.H., Lütke, A., Longwitz, D., Greskötter, K.H., Willburger, R.E., Schmidt, K., et al. The correlation between magnetic resonance imaging and the operative and clinical findings after lumbar microdiscectomy. Int Orthop 22 (1998), 241–244.
8. [8] Lee, S., Moon, C.S., Sul, D., Lee, J., Bae, M., Hong, Y., et al. Comparison of growth factor and cytokine expression in patients with degenerated disc disease and herniated nucleus pulposus. Clin Biochem 42 (2009), 1504–1511.
9. [9] Burneikiene, S., Nelson, E.L., Mason, A., Rajpal, S., Villavicencio, A.T., The duration of symptoms and clinical outcomes in patients undergoing anterior cervical discectomy and fusion for degenerative disc disease and radiculopathy. Spine J 15 (2015), 427–432.
10. [10] Ozaktay, A.C., Kallakuri, S., Takebayashi, T., Cavanaugh, J.M., Asik, I., DeLeo, J.A., et al. Effects of interleukin-1 beta, interleukin-6, and tumor necrosis factor on sensitivity of dorsal root ganglion and peripheral receptive fields in rats. Eur Spine J 15 (2006), 1529–1537.
11. [11] Zhou, Z., Peng, X., Hagshenas, J., Insolera, R., Fink, D.J., Mata, M., A novel cell–cell signaling by microglial transmembrane TNFα with implications for neuropathic pain. Pain 151 (2010), 296–306.
12. [12] DeLeo, J.A., Colburn, R.W., Rickman, A.J., Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy. Brain Res 759 (1997), 50–55.
13. [13] Uceyler, N., Rogausch, J.P., Toyka, K.V., Sommer, C., Differential expression of cytokines in painful and painless neuropathies. Neurology 69 (2007), 42–49.
14. [14] Koch, A., Zacharowski, K., Boehm, O., Stevens, M., Lipfert, P., von Giesen, H.J., et al. Nitric oxide and pro-inflammatory cytokines correlate with pain intensity in chronic pain patients. Inflamm Res 56 (2007), 32–37.
15. [15] Uceyler, N., Kafke, W., Riediger, N., He, L., Necula, G., Toyka, K.V., et al. Elevated proinflammatory cytokine expression in affected skin in small fiber neuropathy. Neurology 74 (2010), 1806–1813.
16. [16] Shamji, M.F., Setton, L.A., Jarvis, W., So, S., Chen, J., Jing, L., et al. Proinflammatory cytokine expression profile in degenerated and herniated human intervertebral disc tissues. Arthritis Rheum 62 (2010), 1974–1982.
17. [17] Burke, J.G., Watson, R.W., McCormack, D., Dowling, F.E., Walsh, M.G., Fitzpatrick, J.M., Intervertebral discs which cause low back pain secrete high levels of proinflammatory mediators. J Bone Joint Surg Br 84 (2002), 196–201.
18. [18] Barksby, H.E., Milner, J.M., Patterson, A.M., Peake, N.J., Hui, W., Robson, T., et al. Matrix metalloproteinase 10 promotion of collagenolysis via procollagenase activation: implications for cartilage degradation in arthritis. Arthritis Rheum 54 (2006), 3244–3253.
19. [19] Séguin, C.A., Pilliar, R.M., Roughley, P.J., Kandel, R.A., Tumor necrosis factor-alpha modulates matrix production and catabolism in nucleus pulposus tissue. Spine 30 (2005), 1940–1948.
20. [20] Andrade, P., Visser-Vandewalle, V., Philippens, M., Daemen, M.A., Steinbusch, H.W., Buurman, W.A., et al. TNF-alpha levels correlate with postoperative pain severity in lumbar disc hernia patients: opposite clinical effects between TNF receptor 1 and 2. Pain 152 (2011), 2645–2652.
21. [21] Takahashi, H., Suguro, T., Okazima, Y., Motegi, M., Okada, Y., Kakiuchi, T., Inflammatory cytokines in the herniated disc of the lumbar spine. Spine 21 (1996), 218–224.
22. [22] Olmarker, K., Larsson, K., Tumor necrosis factor alpha and nucleus-pulposus-induced nerve root injury. Spine 23 (1998), 2538–2544.